These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 2510285

  • 1. Effects of rioprostil on gastric acid and pepsin secretion in man: a review of studies in healthy volunteers.
    Demol P, Singer MV, Dammann HG, Richardson CT, Weihrauch TR.
    Scand J Gastroenterol Suppl; 1989; 164():74-9; discussion 79-80. PubMed ID: 2510285
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of gastric secretion in man by rioprostil, a new synthetic methyl prostaglandin E1.
    Demol P, Wingender W, Weihrauch TR, Graefe KH.
    Arzneimittelforschung; 1985; 35(5):861-3. PubMed ID: 3927929
    [Abstract] [Full Text] [Related]

  • 3. Rioprostil and the gastric mucus-bicarbonate barrier.
    Guslandi M, Fasani R, Tittobello A.
    Scand J Gastroenterol Suppl; 1989; 164():92-5; discussion 95-6. PubMed ID: 2510287
    [Abstract] [Full Text] [Related]

  • 4. [Rioprostil 600 micrograms at night: marked inhibition of nocturnal intragastric acidity in man].
    Dammann HG, Rehner M, Walter TA, Müller P, Simon B.
    Z Gastroenterol; 1986 May; 24(5):245-9. PubMed ID: 3088858
    [Abstract] [Full Text] [Related]

  • 5. Gastric effects of a prostaglandin E1-derivate (rioprostil) on acid, alkaline, and mucus secretion.
    Guslandi M, Passaretti S, Tittobello A, Fasani R.
    Clin Ther; 1986 May; 8(6):619-23. PubMed ID: 3098425
    [Abstract] [Full Text] [Related]

  • 6. Effect of rioprostil, an oral prostaglandin E1 analogue, on lower oesophageal sphincter pressure and on the motility of the distal oesophagus in healthy volunteers.
    Baunack AR, Demol P, Froese G, Kuhlmann J, Weihrauch TR.
    Scand J Gastroenterol Suppl; 1989 May; 164():120-5; discussion 125-6. PubMed ID: 2510255
    [Abstract] [Full Text] [Related]

  • 7. Gastric antisecretory and antigastrolesive pharmacology of rioprostil.
    Shriver DA, Katz LB, Rosenthale ME.
    Scand J Gastroenterol Suppl; 1989 May; 164():10-20. PubMed ID: 2510252
    [Abstract] [Full Text] [Related]

  • 8. Effects of rioprostil on the postprandial glucose, GIP, insulin and gastrin levels in volunteers.
    Demol P, Wingender W.
    Scand J Gastroenterol Suppl; 1989 May; 164():112-7. PubMed ID: 2510253
    [Abstract] [Full Text] [Related]

  • 9. Effect of rioprostil on the gastric acid and bicarbonate secretion in patients with gastric ulcer.
    Krastev Z, Deredjian S, Matincheva R, Spasova Z, Karakasheva V.
    Scand J Gastroenterol Suppl; 1989 May; 164():141-5. PubMed ID: 2510258
    [Abstract] [Full Text] [Related]

  • 10. Effect of rioprostil, 600 micrograms, on the interdigestive myoelectrical activity of the humans small intestine.
    Vantrappen G, Janssens J.
    Scand J Gastroenterol Suppl; 1989 May; 164():133-8; discussion 138-9. PubMed ID: 2510257
    [Abstract] [Full Text] [Related]

  • 11. Influence of chronic rioprostil treatment on gastric endocrine function.
    Koop H, Schwarting H, Eckel U, Wagenknecht J, Hallfeldt U, Arnold R.
    Scand J Gastroenterol Suppl; 1989 May; 164():104-10; discussion 110-1. PubMed ID: 2573147
    [Abstract] [Full Text] [Related]

  • 12. Effect of rioprostil, a synthetic prostaglandin E1 on meal-stimulated gastric acid secretion and plasma gastrin levels in humans.
    Schulte K, Singer MV, Eysselein V, Demol P, Goebell H.
    Digestion; 1987 May; 36(3):162-7. PubMed ID: 3109990
    [Abstract] [Full Text] [Related]

  • 13. Selective gastric antilesion properties of rioprostil, a prostaglandin E1 analog, in rats and dogs.
    Katz LB, Shriver DA, Tobia AJ, Rosenthale ME.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):927-33. PubMed ID: 3116199
    [Abstract] [Full Text] [Related]

  • 14. Antisecretory and antigastrin effects of rioprostil in gastric fistula dogs.
    Katz LB, Genna T, Greeley GH, Shriver DA.
    Dig Dis Sci; 1987 Nov; 32(11):1268-74. PubMed ID: 3117511
    [Abstract] [Full Text] [Related]

  • 15. Effect of rioprostil, an oral prostaglandin E1 (PGE1) analogue, on lower esophageal sphincter pressure and on the motility of the distal esophagus in healthy volunteers.
    Baunack AR, Froese G, Demol P, Wargenau M, Ruoff HJ, Weihrauch TR.
    Z Gastroenterol; 1988 Apr; 26(4):199-203. PubMed ID: 3149082
    [Abstract] [Full Text] [Related]

  • 16. Antigastrolesive, gastric antisecretory, diarrheagenic and mucus-stimulating effects in rats following topically applied rioprostil, a synthetic prostaglandin E1 analog.
    Katz LB, Genna T, Scott CK, Rosenthale ME, Shriver DA.
    Life Sci; 1987 Sep 28; 41(13):1591-8. PubMed ID: 3114582
    [Abstract] [Full Text] [Related]

  • 17. The antigastrolesive activity of rioprostil, a 16-methyl prostaglandin-E1 analogue in healthy volunteers.
    Cohen A, Tolman KG, Lewis GP, Brown S, van Horn A, McCormack GH, Simon DM.
    Scand J Gastroenterol Suppl; 1989 Sep 28; 164():81-90; discussion 90-1. PubMed ID: 2510286
    [Abstract] [Full Text] [Related]

  • 18. Prevention of the acetylsalicylic acid-induced changes of the gastric potential difference by the new synthetic prostaglandin E1 analogue rioprostil.
    Demol P, Schmitz HD, Weihrauch TR, Kuhlmann J.
    Arzneimittelforschung; 1986 Sep 28; 36(9):1406-8. PubMed ID: 3098255
    [Abstract] [Full Text] [Related]

  • 19. The effects of rioprostil on gastric emptying and intragastric acidity.
    Penston JG, Johnston DA, Wormsley KG.
    Hepatogastroenterology; 1986 Jun 28; 33(3):120-2. PubMed ID: 3091468
    [Abstract] [Full Text] [Related]

  • 20. Omeprazole inhibits nocturnal and pentagastrin-stimulated gastric secretion in man.
    Wilson JA, Boyd EJ, Wormsley KG.
    Dig Dis Sci; 1984 Sep 28; 29(9):797-801. PubMed ID: 6432499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.